Health Related Quality of Life in Patients with Side-Effects after Antimuscarinic Treatment for Overactive Bladder-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Health Related Quality of Life in Patients with Side-Effects after Antimuscarinic Treatment for Overactive Bladder

Published:2016-06-12 Issue:3 Volume:9 Page:171-175
ISSN:1757-5664
Container-title:LUTS: Lower Urinary Tract Symptoms
language:en
Short-container-title:Lower Urinary Tract Symptoms

Author:

KIM Aram¹,LEE Kyu-Sung²,JUNG Rangrhee³,NA Selee⁴,KIM Joon-chul⁵,KIM Hyeong Gon⁶,CHOO Myung-Soo¹

Affiliation:

1. Department of Urology, Asan Medical Center; University of Ulsan College of Medicine; Seoul Korea

2. Department of Urology, Samsung Medical Center; Sungkyunkwan University School of Medicine; Seoul Korea

3. HyeRang Company; Seoul Korea

4. Department of Computer science and Information system; Hanyang Women's University; Seoul Korea

5. Department of Urology, Bucheon St. Mary's hospital; The Catholic University of Korea; Seoul Korea

6. Department of Urology, Konkuk University Hospital; Konkuk University School of Medicine; Seoul Korea

Funder

Astellas Pharma Korea Inc.

Publisher

Wiley

Subject

Urology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/luts.12132/fullpdf

Reference12 articles.

1. Clinical uroradiology: the standardisation of terminology for lower urinary tract function and dysfunction;Barozzi;Radiol Med,2010

2. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study;Irwin;Eur Urol,2006

3. Prevalence of overactive bladder, urinary incontinence, and lower urinary tract symptoms: results of Korean EPIC study;Lee;World J Urol,2011

4. Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community-based survey;Liberman;Urology,2001

5. A comparison of preference assessment instruments used in a clinical trial: responses to the visual analog scale from the EuroQol EQ-5D and the Health Utilities Index;Glick;Med Decis Making,1999

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. THE EFFECT OF INTRAVESICAL ONABOTULINUM TOXIN A TREATMENT ON QUALITY OF LIFE IN PATIENTS WITH OVERACTIVE BLADDER;Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi;2023-03-08

2. Efficacy of non‐pharmacological interventions in patients with overactive bladder: A protocol for systematic review and network meta‐analysis;Nursing Open;2021-09-25

3. Vibegron improves quality‐of‐life measures in patients with overactive bladder: Patient‐reported outcomes from the EMPOWUR study;International Journal of Clinical Practice;2021-01-22

4. Beyond botulinum neurotoxin A for chemodenervation of the bladder;Current Opinion in Urology;2021-01-04

5. The use of mirabegron in neurogenic bladder: a systematic review;World Journal of Urology;2019-12-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3